SAFETY DATA SHEET
LymphoTrack® Dx Assays - MiSeqTM

Catalog Number

Descrip�on91210009

LymphoTrack Dx IGH FR1 Assay Kit A - MiSeq

91210039

LymphoTrack Dx IGH FR1 Assay Panel - MiSeq

91210059

LymphoTrack Dx IGHV Leader Soma�c Hypermuta�on Assay Kit A - MiSeq

91210069

LymphoTrack Dx IGHV Leader Soma�c Hypermuta�on Assay Panel - MiSeq

91210089

LymphoTrack Dx IGH FR2 Assay Kit A - MiSeq

91210099

LymphoTrack Dx IGH FR2 Assay Panel - MiSeq

91210109

LymphoTrack Dx IGH FR3 Assay Kit A - MiSeq

91210119

LymphoTrack Dx IGH FR3 Assay Panel - MiSeq

91210129

LymphoTrack Dx IGH FR1/2/3 Assay Kit A - MiSeq

91210139

LymphoTrack Dx IGH FR1/2/3 Assay Panel - MiSeq

91220009

LymphoTrackDx IGK Assay Kit A - MiSeq

91220019

LymphoTrack Dx IGK Assay Panel - MiSeq

92250009

LymphoTrack Dx TRB Assay Kit A - MiSeq

92250019

LymphoTrack Dx TRB Assay Panel - MiSeq

92270009

LymphoTrack Dx TRG Assay Panel - MiSeq

92270019

LymphoTrack Dx TRG Assay Kit A - MiSeq

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

1 / 24

SAFETY DATA SHEETThis safety data sheet was created pursuant to the requirements of:Regula�on (EC) No. 1907/2006 as amended by Commission Regula�on (EU)2020/878 and Regula�on (EC) No. 1272/2008
Issuing Date 27-Apr-2023

Revision Date 27-Apr-2023

Revision Number 1

SECTION 1: Iden�ﬁca�on of the substance/mixture and of the company/undertaking
1.1.

Product iden�ﬁer
Product Code(s)Product Name

Synonyms

40880008

IGH SHM Posi�ve Control DNA

None

40880009

IGH Posi�ve Control

None40880018

IGK Posi�veNone40880058

TRB Posi�ve Control

None40920018

NGS Nega�ve Control

None42270019

TRG POS (+) Control

None

Pure substance/mixture

Mixture1.2.

Relevant iden�ﬁed uses of the substance or mixture and uses advised against
Recommended use
Assay reagent
Uses advised against
For professional use only

1.3.

Details of the supplier of the safety data sheet
Importer
Invivoscribe Technologies
Zeppelinstrasse 185399 Hallbergmoos
Germany
Phone: +49 89 904 299 800

Supplier
Invivoscribe, Inc.
10222 Barnes Canyon Rd
Bldg. 1San Diego, CA 92121
Phone: +1 858-224-6600

Distributor
Invivoscribe Technologies, SARL
c/o Ficorec Domicilia�on Services
132, Boulevard Michelet
Hall Nord – 5ème étage
13008 Marseille
FRANCE
Tel: +33 (0)4 42 01 78 10

For further informa�on, please contact
E-mail address
customerservice@invivoscribe.com
1.4.

Emergency telephone number
Emergency telephone+49 89 904 299 800 (M-F 8:00 – 16:30 CET)Emergency telephone - §45 - (EC)1272/2008
Europe112

SECTION 2: Hazards iden�ﬁca�on
2.1.

Classiﬁca�on of the substance or mixture
Classiﬁcation according to Regulation (EC) No. 1272/2008 [CLP]This substance is classiﬁed as not hazardous according to regula�on (EC) 1272/2008 [CLP].

2.2.

Label elements
Hazard statements
Not classiﬁed.

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

2 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 2: Hazards iden�ﬁca�on
Unknown aqua�c toxicity
2.3.

Other hazards
No informa�on available.
Endocrine Disruptor
Informa�on

Contains 0 % of components with unknown hazards to the aqua�c environment.

This product does not contain any known or suspected endocrine disruptors.

SECTION 3: Composi�on/informa�on on ingredients
3.1

Substances
The product contains no substances which at their given concentra�on, are considered to be hazardous to health.
Full text of H- and EUH-phrases: see sec�on 16
Acute Toxicity Estimate
If LD50/LC50 data is not available or does not correspond to the classiﬁcation category, then the appropriate conversion value
from CLP Annex I, Table 3.1.2, is used to calculate the acute toxicity estimate (ATEmix) for classifying a mixture based on its
components
This product does not contain candidate substances of very high concern at a concentra�on >=0.1% (Regula�on (EC) No. 1907/2006(REACH), Ar�cle 59)

SECTION 4: First aid measures
4.1.

Descrip�on of ﬁrst aid measures
Inhala�on
Remove to fresh air. Get medical aten�on if symptoms occur.
Eye contact
Rinse thoroughly with plenty of water for at least 15 minutes, li�ing lower and upper eyelids.
Consult a physician.
Skin contact
Wash skin with soap and water. Get medical aten�on if symptoms occur.
Inges�on
Do NOT induce vomi�ng. Never give anything by mouth to an unconscious person. Rinse mouth.
Get medical aten�on if symptoms occur.

4.2.

Most important symptoms and eﬀects, both acute and delayed
Symptoms
None known.
Eﬀects of Exposure
No informa�on available.

4.3.

Indica�on of any immediate medical aten�on and special treatment needed
Note to physicians
Treat symptoma�cally.

SECTION 5: Fireﬁgh�ng measures
5.1.

Ex�nguishing media
Suitable Ex�nguishing Media
Unsuitable ex�nguishing media

Use ex�nguishing measures that are appropriate to local circumstances and thesurrounding environment.
No informa�on available.

5.2.

Special hazards arising from the substance or mixture
Speciﬁc hazards arising from the chemical
No informa�on available.

5.3.

Advice for ﬁreﬁghters
Special protec�ve equipment andprecau�ons for ﬁre-ﬁghters

Fireﬁghters should wear self-contained breathing apparatus and full ﬁreﬁgh�ng
turnout gear. Use personal protec�on equipment.

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

3 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 6: Accidental release measures
6.1.

Personal precau�ons, protec�ve equipment and emergency procedures
Personal precau�ons
Ensure adequate ven�la�on.
For emergency responders
Use personal protec�on recommended in Sec�on 8.

6.2.

Environmental precau�ons
Environmental precau�ons

See Sec�on 12 for addi�onal Ecological Informa�on.

6.3.

Methods and material for containment and cleaning up
Methods for containment
Prevent further leakage or spillage if safe to do so.
Methods for cleaning up
Dam up. Soak up with inert absorbent material. Take up mechanically, placing in appropriate
containers for disposal.
Preven�on of secondary hazards
Clean contaminated objects and areas thoroughly observing environmental regula�ons.

6.4.

Reference to other sec�ons
Reference to other sec�ons

See sec�on 8 for more informa�on See sec�on 13 for more informa�on

SECTION 7: Handling and storage
7.1.

Precau�ons for safe handling
Advice on safe handling
General hygiene
considera�ons

Handle in accordance with good industrial hygiene and safety prac�ce.
Handle in accordance with good industrial hygiene and safety prac�ce.

7.2.

Condi�ons for safe storage, including any incompa�bili�esStorage Condi�ons
Keep containers �ghtly closed in a dry, cool and well-ven�lated place.
Storage class (TRGS 510)
Storage class 10.

7.3.

Speciﬁc end use(s)Speciﬁc use(s)The iden�ﬁed uses for this product are detailed in Sec�on 1.2.

SECTION 8: Exposure controls/personal protec�on
8.1.

Control parameters
Exposure Limits

This product, as supplied, does not contain any hazardous materials with occupa�onal exposure
limits established by the region speciﬁc regulatory bodies.

Biological occupa�onal exposure limits
This product, as supplied, does not contain any hazardous materials with biological limits established by the region-speciﬁc
regulatory bodies.
Derived No Eﬀect Level (DNEL) - Workers
No informa�on available.
Derived No Eﬀect Level (DNEL) - General Public
No informa�on available.
Predicted No Eﬀect Concentra�on (PNEC)
No informa�on available.
8.2.

Exposure controls
Engineering controls

Personal protec�ve equipment
Eye/face protec�onShowers
Eyewash sta�ons
Ven�la�on systems.

Wear safety glasses with side shields (or goggles). Eye protec�on must conform to standard
EN 166.

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

4 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 8: Exposure controls/personal protec�on
Hand protec�on
Skin and body protec�on
Respiratory protec�onGeneral hygiene considera�ons
Environmental exposure controls

Wear suitable gloves. Gloves must conform to standard EN 374.
Wear suitable protec�ve clothing. (EN ISO 6529).
No protec�ve equipment is needed under normal use condi�ons. If exposure limits are
exceeded or irrita�on is experienced, ven�la�on and evacua�on may be required.
Handle in accordance with good industrial hygiene and safety prac�ce.
No informa�on available.

SECTION 9: Physical and chemical proper�es
9.1.

Informa�on on basic physical and chemical proper�es
Appearance
Physical state
LiquidColor
Colorless
Odor
Odorless
Odor thresholdNo informa�on available
PropertyMel�ng point / freezing pointIni�al boiling point and boiling range
Flammability
Flammability Limit in Air
Upper ﬂammability or explosive limits
Lower ﬂammability or explosive limits
Flash point
Autoigni�on temperature
Decomposi�on temperaturepH
pH (as aqueous solu�on)
Kinema�c viscosity
Dynamic viscosity
Water solubility
Solubility(ies)Par��on coeﬃcient
Vapor pressure
Rela�ve density
Bulk density
Liquid density
Rela�ve vapor densityPar�cle characteris�cs
Par�cle sizePar�cle size distribu�on

9.2.

ValuesRemarks • Method
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available

Other informa�on
9.2.1.
9.2.2.

Information with regard to physical hazard classes
Not applicable
Other safety characteristics
No informa�on available

SECTION 10: Stability and reac�vity
10.1. Reac�vity
SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

5 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 10: Stability and reac�vity
Reac�vity

None under normal use condi�ons.

10.2. Chemical stability
Stability
Explosion data

Stable under normal condi�ons.

Sensi�vity to mechanical impact

None.

Sensi�vity to sta�c discharge

None.

10.3. Possibility of hazardous reac�ons
Possibility of hazardous reac�ons

None under normal processing.

10.4. Condi�ons to avoid
Condi�ons to avoid

None known based on informa�on supplied.

10.5. Incompa�ble materials
Incompa�ble materials

None known based on informa�on supplied.

10.6. Hazardous decomposi�on products
Hazardous decomposi�on products

None known based on informa�on supplied.

SECTION 11: Toxicological informa�on
11.1. Informa�on on hazard classes as deﬁned in Regula�on (EC) No 1272/2008
Informa�on on likely routes of exposure
Product Informa�on
Inhala�on
Speciﬁc test data for the substance or mixture is not available.
Eye contact

Speciﬁc test data for the substance or mixture is not available. Contact with eyes may cause irrita�on.

Skin contact

Speciﬁc test data for the substance or mixture is not available.

Inges�on

Speciﬁc test data for the substance or mixture is not available.

Symptoms related to the physical, chemical and toxicological characteris�cs
Symptoms
None known.
Acute toxicity
Numerical measures of toxicity
Based on available data, the classiﬁca�on criteria are not met.
Component Informa�on
Delayed and immediate eﬀects as well as chronic eﬀects from short and long-term exposure
Skin corrosion/irrita�on
Based on available data, the classiﬁca�on criteria are not met.
Serious eye damage/eye irrita�on
Based on available data, the classiﬁca�on criteria are not met.
Respiratory or skin sensi�za�on
Based on available data, the classiﬁca�on criteria are not met.
Germ cell mutagenicity
Based on available data, the classiﬁca�on criteria are not met.
Carcinogenicity
Based on available data, the classiﬁca�on criteria are not met.
Reproduc�ve toxicity
Based on available data, the classiﬁca�on criteria are not met.
STOT - single exposure
Based on available data, the classiﬁca�on criteria are not met.
STOT - repeated exposure
Based on available data, the classiﬁca�on criteria are not met.
Aspira�on hazard
Based on available data, the classiﬁca�on criteria are not met.
11.2. Informa�on on other hazards

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

6 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 11: Toxicological informa�on
11.2.1.
11.2.2.

Endocrine disrupting properties
Endocrine disrup�ng proper�es
Other information
Other adverse eﬀects

This product does not contain any known or suspected endocrine disruptors.
No informa�on available.

SECTION 12: Ecological informa�on
12.1. Toxicity
Ecotoxicity
Unknown aqua�c toxicity

Based on available data, the classiﬁca�on criteria are not met. Based on available data, theclassiﬁca�on criteria are not met.
Contains 0 % of components with unknown hazards to the aqua�c environment.

12.2. Persistence and degradability
Persistence and degradability

No informa�on available.

12.3. Bioaccumula�ve poten�al
Bioaccumula�on

No informa�on available.

12.4. Mobility in soil
Mobility in soil

No informa�on available.

12.5. Results of PBT and vPvB assessment
PBT and vPvB assessment
The product does not contain any substance(s) classiﬁed as PBT or vPvB.
12.6. Endocrine disrup�ng proper�es
Endocrine disrup�ng
proper�es
12.7. Other adverse eﬀects
Other adverse eﬀects

This product does not contain any known or suspected endocrine disruptors.

No informa�on available.

SECTION 13: Disposal considera�ons
13.1. Waste treatment methods
Waste from residues/unused
products
Contaminated packaging
Waste codes / waste
designa�ons according to EWC/ AVV

Dispose of in accordance with local regula�ons. Dispose of waste in accordance withenvironmental legisla�on.
Do not reuse empty containers.
According to the European Waste Catalog, Waste Codes are not product speciﬁc, but applica�on
speciﬁc. Waste codes should be assigned by the user based on the applica�on for which the
product was used.

SECTION 14: Transport informa�on
IMDG
14.1
14.2
14.3
14.4
14.5
14.6

Not regulated
UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions

Not regulated
Not regulated
Not regulated
Not applicableNot applicable
None

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

7 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 14: Transport informa�on

RID

ADR

IATA

14.7

Mari�me transport in bulk according
to IMO instruments

14.1
14.2
14.3
14.4
14.5
14.6

UN numberUN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions

14.1
14.2
14.3
14.4
14.5
14.6

14.1
14.2
14.3
14.4
14.5
14.6

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions
Note:

No informa�on available

Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicableNone
Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicableNone
Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable
None
None

SECTION 15: Regulatory informa�on
15.1. Safety, health and environmental regula�ons/legisla�on speciﬁc for the substance or mixtureNa�onal regula�ons
Germany
Water hazard class (WGK)
non-hazardous to water (nwg)
European Union
Take note of Direc�ve 98/24/EC on the protec�on of the health and safety of workers from the risks related to chemical agents at
work.
Authoriza�ons and/or restric�ons on use:
This product does not contain substances subject to authoriza�on (Regula�on (EC) No. 1907/2006 (REACH), Annex XIV) This productdoes not contain substances subject to restric�on (Regula�on (EC) No. 1907/2006 (REACH), Annex XVII)Persistent Organic Pollutants
Not applicable
Ozone-deple�ng substances (ODS) regula�on (EC) 1005/2009
Not applicable
Interna�onal Inventories

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

8 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 15: Regulatory informa�on
Contact supplier for inventory compliance status
15.2. Chemical safety assessment
Chemical Safety Report

No informa�on available

SECTION 16: Other informa�on
Key or legend to abbrevia�ons and acronyms used in the safety data sheet
Legend
ATE: Acute Toxicity Es�mate
SVHC: Substances of Very High Concern for Authoriza�on:
PBT: Persistent, Bioaccumula�ve, and Toxic (PBT) Substances
vPvB: Very Persistent and very Bioaccumula�ve (vPvB) Substances
Legend Sec�on 8: Exposure controls/personal protec�on
TWA
TWA (�me-weighted average)
Ceiling
Maximum limit value
SCBA
Self-contained breathing apparatus
Classiﬁca�on procedure
Classiﬁca�on according to Regula�on (EC) No. 1272/2008 [CLP]
Acute oral toxicity
Acute dermal toxicity
Acute inhala�on toxicity - gas
Acute inhala�on toxicity - vapor
Acute inhala�on toxicity - dust/mist
Skin corrosion/irrita�on
Serious eye damage/eye irrita�on
Respiratory sensi�za�on
Skin sensi�za�on
Mutagenicity
Carcinogenicity
Reproduc�ve toxicity
STOT - single exposure
STOT - repeated exposure
Acute aqua�c toxicity
Chronic aqua�c toxicity
Aspira�on hazard
Ozone

STEL
*

STEL (Short Term Exposure Limit)
Skin designa�on

Method Used
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
On basis of test data
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method

Key literature references and sources for data used to compile the SDS
Agency for Toxic Substances and Disease Registry (ATSDR)
U.S. Environmental Protec�on Agency ChemView Database
European Food Safety Authority (EFSA)
European Chemicals Agency (ECHA) Commitee for Risk Assessment (ECHA_RAC)
European Chemicals Agency (ECHA) (ECHA_API)
EPA (Environmental Protec�on Agency)
Acute Exposure Guideline Level(s) (AEGL(s))
U.S. Environmental Protec�on Agency Federal Insec�cide, Fungicide, and Roden�cide Act
U.S. Environmental Protec�on Agency High Produc�on Volume Chemicals
SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

9 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 16: Other informa�on
Food Research Journal
Hazardous Substance Database
Interna�onal Uniform Chemical Informa�on Database (IUCLID)
Japan GHS Classiﬁca�onAustralia Na�onal Industrial Chemicals No�ﬁca�on and Assessment Scheme (NICNAS)
NIOSH (Na�onal Ins�tute for Occupa�onal Safety and Health)Na�onal Library of Medicine's ChemID Plus (NLM CIP)
Na�onal Library of Medicine’s PubMed database (NLM PUBMED)
United States of America Na�onal Toxicology Program (NTP)New Zealand's Chemical Classiﬁca�on and Informa�on Database (CCID)
Organiza�on for Economic Co-opera�on and Development Environment, Health, and Safety Publica�ons
Organiza�on for Economic Co-opera�on and Development High Produc�on Volume Chemicals Program
Organiza�on for Economic Co-opera�on and Development Screening Informa�on Data Set
World Health Organiza�on
Issuing Date
Revision Date
Revision Note

27-Apr-2023
27-Apr-2023
Ini�al Release.

This safety data sheet complies with the requirements of Commission Regula�on (EU) 2020/878 of 18 June 2020 amending Regula�on(EC) No. 1907/2006
Disclaimer
The informa�on provided in this Safety Data Sheet is correct to the best of our knowledge, informa�on and belief at the date of its
publica�on. The informa�on given is designed only as a guidance for safe handling, use, processing, storage, transporta�on, disposal
and release and is not to be considered a warranty or quality speciﬁca�on. The informa�on relates only to the speciﬁc material
designated and may not be valid for such material used in combina�on with any other materials or in any process, unless speciﬁed in
the text.

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

10 / 24

SAFETY DATA SHEETThis safety data sheet was created pursuant to the requirements of:Regula�on (EC) No. 1907/2006 as amended by Commission Regula�on (EU)2020/878 and Regula�on (EC) No. 1272/2008
Issuing Date 27-Apr-2023

Revision Date 27-Apr-2023

Revision Number 1

SECTION 1: Iden�ﬁca�on of the substance/mixture and of the company/undertaking
1.1.

Product iden�ﬁer
Product Code(s)21210009CE
21210019CE
21210029CE
21210039CE
21210049CE
21210059CE
21210069CE
21210079CE
21210089CE
21210099CE
21210109CE
21210119CE
21210129CE
21210139CE
21210149CE
21210159CE
21210169CE
21210179CE
21210189CE
21210199CE
21210209CE
21210219CE
21210229CE
21210239CE
21210249CE
21210259CE
21210269CE
21210279CE
21210289CE
21210299CE
21210309CE
21210319CE
21210329CE
21210339CE
21210349CE
21210359CE
21210369CE
21210379CE
21210389CE
21210399CE
21210409CE

Product Name
IGH FR1 MiSeq 01
IGH FR1 MiSeq 02
IGH FR1 MiSeq 03
IGH FR1 MiSeq 04
IGH FR1 MiSeq 05
IGH FR1 MiSeq 06
IGH FR1 MiSeq 07
IGH FR1 MiSeq 08
IGH FR1 MiSeq 09
IGH FR1 MiSeq 10
IGH FR1 MiSeq 11
IGH FR1 MiSeq 12
IGH FR1 MiSeq 13
IGH FR1 MiSeq 14
IGH FR1 MiSeq 15
IGH FR1 MiSeq 16
IGH FR1 MiSeq 18
IGH FR1 MiSeq 19
IGH FR1 MiSeq 20
IGH FR1 MiSeq 21
IGH FR1 MiSeq 22
IGH FR1 MiSeq 23
IGH FR1 MiSeq 25
IGH FR1 MiSeq 27
IGH Leader MiSeq 01
IGH Leader MiSeq 02
IGH Leader MiSeq 03
IGH Leader MiSeq 04
IGH Leader MiSeq 05
IGH Leader MiSeq 06
IGH Leader MiSeq 07
IGH Leader MiSeq 08
IGH Leader MiSeq 09
IGH Leader MiSeq 10
IGH Leader MiSeq 11
IGH Leader MiSeq 12
IGH Leader MiSeq 13
IGH Leader MiSeq 14
IGH Leader MiSeq 15
IGH Leader MiSeq 16
IGH Leader MiSeq 18

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

Synonyms
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
11 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 1: Iden�ﬁca�on of the substance/mixture and of the company/undertaking
Product Code(s)21210419CE
21210429CE
21210439CE
21210449CE
21210459CE
21210469CE
21210479CE
21210489CE
21210499CE
21210509CE
21210519CE
21210529CE
21210539CE
21210549CE
21210559CE
21210569CE
21210579CE
21210589CE
21210599CE
21210609CE
21210619CE
21210629CE
21210639CE
21210649CE
21210659CE
21210669CE
21210679CE
21210689CE
21210699CE
21210709CE
21210719CE
21210729CE
21210739CE
21210749CE
21210759CE
21210769CE
21210779CE
21210789CE
21210799CE
21210809CE
21210819CE
21210829CE
21210839CE
21210849CE
21210859CE
21210869CE
21210879CE

Product Name
IGH Leader MiSeq 19
IGH Leader MiSeq 20
IGH Leader MiSeq 21
IGH Leader MiSeq 22
IGH Leader MiSeq 23
IGH Leader MiSeq 25
IGH Leader MiSeq 27
IGH FR2 MiSeq 01
IGH FR2 MiSeq 02
IGH FR2 MiSeq 03
IGH FR2 MiSeq 04
IGH FR2 MiSeq 05
IGH FR2 MiSeq 06
IGH FR2 MiSeq 07
IGH FR2 MiSeq 08
IGH FR2 MiSeq 09
IGH FR2 MiSeq 10
IGH FR2 MiSeq 11
IGH FR2 MiSeq 12
IGH FR2 MiSeq 13
IGH FR2 MiSeq 14
IGH FR2 MiSeq 15
IGH FR2 MiSeq 16
IGH FR2 MiSeq 18
IGH FR2 MiSeq 19
IGH FR2 MiSeq 20
IGH FR2 MiSeq 21
IGH FR2 MiSeq 22
IGH FR2 MiSeq 23
IGH FR2 MiSeq 25
IGH FR2 MiSeq 27
IGH FR3 MiSeq 01
IGH FR3 MiSeq 02
IGH FR3 MiSeq 03
IGH FR3 MiSeq 04
IGH FR3 MiSeq 05
IGH FR3 MiSeq 06
IGH FR3 MiSeq 07
IGH FR3 MiSeq 08
IGH FR3 MiSeq 09
IGH FR3 MiSeq 10
IGH FR3 MiSeq 11
IGH FR3 MiSeq 12
IGH FR3 MiSeq 13
IGH FR3 MiSeq 14
IGH FR3 MiSeq 15
IGH FR3 MiSeq 16

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

Synonyms
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None

12 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 1: Iden�ﬁca�on of the substance/mixture and of the company/undertaking
Product Code(s)21210889CE
21210899CE
21210909CE
21210919CE
21210929CE
21210939CE
21210949CE
21210959CE
21220009CE
21220019CE
21220029CE
21220039CE
21220049CE
21220059CE
21220069CE
21220079CE
21220089CE
21220099CE
21220109CE
21220119CE
21220129CE
21220139CE
21220149CE
21220159CE
21220169CE
21220179CE
21220189CE
21220199CE
21220209CE
21220219CE
21220229CE
21220239CE
22250009CE
22250019CE
22250029CE
22250039CE
22250049CE
22250059CE
22250069CE
22250079CE
22250089CE
22250099CE
22250109CE
22250119CE
22250129CE
22250139CE
22250149CE
22250159CE

Product Name
IGH FR3 MiSeq 18
IGH FR3 MiSeq 19
IGH FR3 MiSeq 20
IGH FR3 MiSeq 21
IGH FR3 MiSeq 22
IGH FR3 MiSeq 23
IGH FR3 MiSeq 25
IGH FR3 MiSeq 27
IGK MiSeq 01
IGK MiSeq 02
IGK MiSeq 03
IGK MiSeq 04
IGK MiSeq 05
IGK MiSeq 06
IGK MiSeq 07
IGK MiSeq 08
IGK MiSeq 09
IGK MiSeq 10
IGK MiSeq 11
IGK MiSeq 12
IGK MiSeq 13
IGK MiSeq 14
IGK MiSeq 15
IGK MiSeq 16
IGK MiSeq 18
IGK MiSeq 19
IGK MiSeq 20
IGK MiSeq 21
IGK MiSeq 22
IGK MiSeq 23
IGK MiSeq 25
IGK MiSeq 27
TRB MiSeq 01
TRB MiSeq 02
TRB MiSeq 03
TRB MiSeq 04
TRB MiSeq 05
TRB MiSeq 06
TRB MiSeq 07
TRB MiSeq 08
TRB MiSeq 09
TRB MiSeq 10
TRB MiSeq 11
TRB MiSeq 12
TRB MiSeq 13
TRB MiSeq 14
TRB MiSeq 15
TRB MiSeq 16

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

Synonyms
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
13 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 1: Iden�ﬁca�on of the substance/mixture and of the company/undertaking
Product Code(s)22250169CE
22250179CE
22250189CE
22250199CE
22250209CE
22250219CE
22250229CE
22250239CE
22270019CE
22270029CE
22270039CE
22270049CE
22270059CE
22270069CE
22270079CE
22270089CE
22270099CE
22270109CE
22270119CE
22270129CE
22270139CE
22270149CE
22270159CE
22270169CE
22270189CE
22270199CE
22270209CE
22270219CE
22270229CE
22270239CE
22270259CE
22270279CE

Product Name
TRB MiSeq 18
TRB MiSeq 19
TRB MiSeq 20
TRB MiSeq 21
TRB MiSeq 22
TRB MiSeq 23
TRB MiSeq 25
TRB MiSeq 27
TRG MiSeq 01
TRG MiSeq 02
TRG MiSeq 03
TRG MiSeq 04
TRG MiSeq 05
TRG MiSeq 06
TRG MiSeq 07
TRG MiSeq 08
TRG MiSeq 09
TRG MiSeq 10
TRG MiSeq 11
TRG MiSeq 12
TRG MiSeq 13
TRG MiSeq 14
TRG MiSeq 15
TRG MiSeq 16
TRG MiSeq 18
TRG MiSeq 19
TRG MiSeq 20
TRG MiSeq 21
TRG MiSeq 22
TRG MiSeq 23
TRG MiSeq 25
TRG MiSeq 27

Pure substance/mixture

Mixture1.2.

Relevant iden�ﬁed uses of the substance or mixture and uses advised against
Recommended use
Assay reagent
Uses advised against
For professional use only

1.3.

Details of the supplier of the safety data sheet
Importer
Invivoscribe Technologies
Zeppelinstrasse 185399 Hallbergmoos
Germany
Phone: +49 89 904 299 800

Synonyms
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None

Supplier
Invivoscribe, Inc.
10222 Barnes Canyon Rd
Bldg. 1San Diego, CA 92121
Phone: +1 858-224-6600

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

Distributor
Invivoscribe Technologies, SARL
c/o Ficorec Domicilia�on Services
132, Boulevard Michelet
Hall Nord – 5ème étage
13008 Marseille
FRANCE
Tel: +33 (0)4 42 01 78 10

14 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 1: Iden�ﬁca�on of the substance/mixture and of the company/undertaking

1.4.

For further informa�on, please contact
E-mail address

customerservice@invivoscribe.com

Emergency telephone number
Emergency telephone+49 89 904 299 800 (M-F 8:00 – 16:30 CET)Emergency telephone - §45 - (EC)1272/2008
Europe112

SECTION 2: Hazards iden�ﬁca�on
2.1.

Classiﬁca�on of the substance or mixture
Classiﬁcation according to Regulation (EC) No. 1272/2008 [CLP]This mixture is classiﬁed as not hazardous according to regula�on (EC) 1272/2008 [CLP]

2.2.

Label elements
Hazard statements

2.3.

Not classiﬁed.
Unknown aqua�c toxicity

Contains 0 % of components with unknown hazards to the aqua�c environment.

Other hazards
Endocrine Disruptor Informa�on

This product does not contain any known or suspected endocrine disruptors.

SECTION 3: Composi�on/informa�on on ingredients
3.1

Substances
Not applicable

3.2

Mixtures
Chemical name

Weight%REACH
registra�onnumberEC No (EU
Index No)Classiﬁca�onaccording toRegula�on (EC) No.
1272/2008 [CLP][C]

Speciﬁcconcentra�onlimit (SCL)

MFactor

M-Factor(long-term)

Dimethyl sulfoxide
1-5
No data
200-664-3
67-68-5
available
Classiﬁcation according to Regulation (EC) No. 1272/2008 [CLP] - Notes[C] - Components with occupational exposure limits and/or biological occupational exposure limits requiring monitoring-

Full text of H- and EUH-phrases: see sec�on 16
Acute Toxicity Estimate
If LD50/LC50 data is not available or does not correspond to the classiﬁcation category, then the appropriate conversion value
from CLP Annex I, Table 3.1.2, is used to calculate the acute toxicity estimate (ATEmix) for classifying a mixture based on its
components
Chemical name
Oral LD50 mg/kg
Dermal LD50
Inhala�on LC50 - 4
Inhala�on LC50 - 4 Inhala�on LC50 - 4
mg/kg
hour - dust/mist hour - vapor hour - gas - ppm
mg/L
mg/L
Dimethyl sulfoxide
28300
40000
5.3353No data available
No data available
67-68-5This product does not contain candidate substances of very high concern at a concentra�on >=0.1% (Regula�on (EC) No. 1907/2006(REACH), Ar�cle 59)

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

15 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 4: First aid measures
4.1.

Descrip�on of ﬁrst aid measures
Inhala�on
Remove to fresh air. Get medical aten�on if symptoms occur.
Eye contact
Rinse thoroughly with plenty of water, also under the eyelids. Get medical aten�on if symptoms occur.
Skin contact
Wash skin with soap and water. Get medical aten�on if symptoms occur.
Inges�on
Do NOT induce vomi�ng. Never give anything by mouth to an unconscious person. Rinse mouth. Get medicalaten�on if symptoms occur.

4.2.

Most important symptoms and eﬀects, both acute and delayed
Symptoms
None known.
Eﬀects of Exposure
No informa�on available.

4.3.

Indica�on of any immediate medical aten�on and special treatment needed
Note to physicians
Treat symptoma�cally.

SECTION 5: Fireﬁgh�ng measures
5.1.

Ex�nguishing media
Suitable Ex�nguishing MediaUse ex�nguishing measures that are appropriate to local circumstances and thesurrounding environment.
No informa�on available.

Unsuitable ex�nguishing media
5.2.

Special hazards arising from the substance or mixture
Speciﬁc hazards arising from the chemical
No informa�on available.

5.3.

Advice for ﬁreﬁghters
Special protec�ve equipment andprecau�ons for ﬁre-ﬁghters

Fireﬁghters should wear self-contained breathing apparatus and full ﬁreﬁgh�ng
turnout gear. Use personal protec�on equipment.

SECTION 6: Accidental release measures
6.1.

Personal precau�ons, protec�ve equipment and emergency procedures
Personal precau�ons
Ensure adequate ven�la�on.
For emergency responders
Use personal protec�on recommended in Sec�on 8.

6.2.

Environmental precau�ons
Environmental precau�ons

6.3.

Methods and material for containment and cleaning up
Methods for containment
Prevent further leakage or spillage if safe to do so.
Methods for cleaning up
Dam up. Soak up with inert absorbent material. Take up mechanically, placing inappropriate containers for disposal.
Preven�on of secondary hazards
Clean contaminated objects and areas thoroughly observing environmental regula�ons.

6.4.

Reference to other sec�ons
Reference to other sec�ons

See Sec�on 12 for addi�onal Ecological Informa�on.

See sec�on 8 for more informa�on See sec�on 13 for more informa�on

SECTION 7: Handling and storage
7.1.

Precau�ons for safe handling
Advice on safe handling
General hygiene considera�ons

Handle in accordance with good industrial hygiene and safety prac�ce.
Handle in accordance with good industrial hygiene and safety prac�ce.

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

16 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 7: Handling and storage
7.2.

Condi�ons for safe storage, including any incompa�bili�esStorage Condi�ons
Keep containers �ghtly closed in a dry, cool and well-ven�lated place.
Storage class (TRGS 510)
Storage class 10.

7.3.

Speciﬁc end use(s)Speciﬁc use(s)The iden�ﬁed uses for this product are detailed in Sec�on 1.2.

SECTION 8: Exposure controls/personal protec�on
8.1.

Control parameters
Exposure Limits
Chemical name
Dimethyl sulfoxide
67-68-5

European Union-

Austria
TWA: 50 ppm
TWA: 160 mg/m3
H*
Czech Republic-

Belgium-

Bulgaria-

Croa�a-Denmark
TWA: 50 ppm
TWA: 160 mg/m3
STEL: 100 ppm
STEL: 320 mg/m3

Estonia
TWA: 50 ppm
TWA: 150 mg/m3
STEL: 150 ppm
STEL: 500 mg/m3
A*
Greece-Finland
TWA: 50 ppm
iho*

Latvia-Lithuania
O*
TWA: 50 ppm
TWA: 150 mg/m3
STEL: 150 ppm
STEL: 500 mg/m3
Spain-

Chemical name
Dimethyl sulfoxide
67-68-5

Cyprus-Chemical name
Dimethyl sulfoxide
67-68-5

France-Germany TRGS
TWA: 50 ppm
TWA: 160 mg/m3
H*

Chemical name
Dimethyl sulfoxide
67-68-5

Ireland-

Italy MDLPS-

Germany DFG
TWA: 50 ppm
TWA: 160 mg/m3
Peak: 100 ppm
Peak: 320 mg/m3*
Italy AIDII-

Chemical name
Dimethyl sulfoxide
67-68-5

Portugal-

Romania-

Slovakia-

Chemical name
Dimethyl sulfoxide
67-68-5

SwedenNGV: 50 ppm
NGV: 150 mg/m3
Vägledande KGV: 150 ppm
Vägledande KGV: 500 mg/m3
H*

Switzerland
TWA: 50 ppm
TWA: 160 mg/m3
STEL: 100 ppm
STEL: 320 mg/m3
H*

Hungary-

Slovenia
TWA: 160 mg/m3
TWA: 50 ppm
STEL: 100 ppm
STEL: 320 mg/m3
K*
United Kingdom-

Biological occupa�onal exposure limits
This product, as supplied, does not contain any hazardous materials with biological limits established by the region speciﬁc
regulatory bodies.
Derived No Eﬀect Level (DNEL) - Workers
Chemical nameOral

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

DermalInhala�on
17 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 8: Exposure controls/personal protec�onDimethyl sulfoxide
67-68-5
Notes
[4]
[5]
[6]
[7]

Predicted No Eﬀect Concentra�on (PNEC)
Chemical nameFreshwater

8.2.

200 mg/kg bw/day [4] [6]484 mg/m3 [4] [6]265 mg/m3 [5] [6]

Systemic health eﬀects.
Local health eﬀects.
Long term.
Short term.

Derived No Eﬀect Level (DNEL) - General Public
Chemical name
Dimethyl sulfoxide
67-68-5
Notes
[4]
[5]
[6]
[7]

Dimethyl sulfoxide
67-68-5

17 mg/L

Chemical nameFreshwater
sediment
13.4 mg/kg
sediment dw

Dimethyl sulfoxide
67-68-5-

Exposure controls
Engineering controls

Oral
60 mg/kg
bw/day [4] [6]Dermal-Inhala�on
120 mg/m3 [4] [6]47 mg/m3 [5] [6]

Systemic health eﬀects.
Local health eﬀects.
Long term.
Short term.

Freshwater(intermitent
release)-Marine waterAir

1.7 mg/L

Marine water(intermitent
release)-Marine sediment

Sewage treatment

Soil

Food chain-

11 mg/L

3.02 mg/kg soil dw

0.7 g/kg food-Showers
Eyewash sta�ons
Ven�la�on systems.

Personal protec�ve equipment
Eye/face protec�on
Hand protec�on
Skin and body protec�on
Respiratory protec�onGeneral hygiene considera�ons
Environmental exposure controls

Wear safety glasses with side shields (or goggles). Eye protec�on must conform tostandard EN 166.
Wear suitable gloves. Gloves must conform to standard EN 374.
Wear suitable protec�ve clothing (EN ISO 6529).
No protec�ve equipment is needed under normal use condi�ons. If exposure
limits are exceeded or irrita�on is experienced, ven�la�on and evacua�on may berequired.
Handle in accordance with good industrial hygiene and safety prac�ce.
No informa�on available.

SECTION 9: Physical and chemical proper�es
9.1.

Informa�on on basic physical and chemical proper�es
Appearance
Clear liquid
Physical state
LiquidColor
Colorless. Light blue, light yellow, light pink. or light orange
Odor
Odorless

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

18 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 9: Physical and chemical proper�es
Odor threshold
PropertyMel�ng point / freezing point

No informa�on available
ValuesRemarks • Method
No data available

Ini�al boiling point and boiling range

No data available

Flammability

No data available

Flammability Limit in Air
Upper ﬂammability or explosive limits

No data available

Lower ﬂammability or explosive limits

No data available

Flash point

No data available

Autoigni�on temperature

No data available

Decomposi�on temperaturepH
pH (as aqueous solu�on)

No data available
7

-

9.5

Kinema�c viscosity

No data available

Dynamic viscosity

No data available

Water solubility
Solubility(ies)

No data available
No data available

Par��on coeﬃcient

No data available

Vapor pressure

No data available

Rela�ve density

No data available

Bulk density

No data available

Liquid Density

No data available

Rela�ve vapor density

No data availablePar�cle characteris�cs
Par�cle Size

No data availablePar�cle Size Distribu�on
9.2.

No data available
No data available

No data available

Other informa�on
9.2.1.
9.2.2.

Information with regard to physical hazard classes
Not applicable
Other safety characteristics
No informa�on available

SECTION 10: Stability and reac�vity
10.1. Reac�vity
Reac�vity
10.2. Chemical stability
Stability
Explosion data

None under normal use condi�ons.

Stable under normal condi�ons.

Sensi�vity to mechanical impact

None.

Sensi�vity to sta�c discharge

None.

10.3. Possibility of hazardous reac�ons
Possibility of hazardous reac�ons

None under normal processing.

10.4. Condi�ons to avoid
SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

19 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 10: Stability and reac�vity
Condi�ons to avoid

None known based on informa�on supplied.

10.5. Incompa�ble materials
Incompa�ble materials

None known based on informa�on supplied.

10.6. Hazardous decomposi�on products
Hazardous decomposi�on products

None known based on informa�on supplied.

SECTION 11: Toxicological informa�on
11.1. Informa�on on hazard classes as deﬁned in Regula�on (EC) No 1272/2008
Informa�on on likely routes of exposure
Product Informa�on
Inhala�on

Speciﬁc test data for the substance or mixture is not available.

Eye contact

Speciﬁc test data for the substance or mixture is not available. Contact with eyes may cause irrita�on.

Skin contact

Speciﬁc test data for the substance or mixture is not available.

Inges�on

Speciﬁc test data for the substance or mixture is not available.

Symptoms related to the physical, chemical and toxicological characteris�cs
Symptoms
None known.
Acute toxicity
Numerical measures of toxicity
Based on available data, the classiﬁca�on criteria are not met.
Component Informa�on
Chemical name
Dimethyl sulfoxide

Oral LD50= 28300 mg/kg( Rat )

Dermal LD50
= 40000 mg/kg ( Rat )Inhala�on LC50
> 5.33 mg/L ( Rat ) 4 h

Delayed and immediate eﬀects as well as chronic eﬀects from short and long-term exposure
Skin corrosion/irrita�on
Based on available data, the classiﬁca�on criteria are not met.
Serious eye damage/eye irrita�on
Based on available data, the classiﬁca�on criteria are not met.
Respiratory or skin sensi�za�on
Based on available data, the classiﬁca�on criteria are not met.
Germ cell mutagenicity
Based on available data, the classiﬁca�on criteria are not met.
Carcinogenicity
Based on available data, the classiﬁca�on criteria are not met.
Reproduc�ve toxicity
Based on available data, the classiﬁca�on criteria are not met.
STOT - single exposure
Based on available data, the classiﬁca�on criteria are not met.
STOT - repeated exposure
Based on available data, the classiﬁca�on criteria are not met.
Aspira�on hazard
Based on available data, the classiﬁca�on criteria are not met.
11.2. Informa�on on other hazards
11.2.1.
Endocrine disrupting properties
Endocrine disrup�ng proper�es
11.2.2.
Other information
Other adverse eﬀects

This product does not contain any known or suspected endocrine disruptors.
No informa�on available.

SECTION 12: Ecological informa�on
12.1. Toxicity
SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

20 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 12: Ecological informa�on
Ecotoxicity

Based on available data, the classiﬁca�on criteria are not met. Based on available data, theclassiﬁca�on criteria are not met.
Contains 0 % of components with unknown hazards to the aqua�c environment.

Unknown aqua�c toxicity
Chemical name
Dimethyl sulfoxide
67-68-5

Algae/aqua�cplants
-12.2. Persistence and degradability
Persistence and degradability

Fish
LC50: =34000mg/L (96h, Pimephales promelas)
LC50: 33 - 37g/L (96h, Oncorhynchus mykiss)
LC50: >40g/L (96h, Lepomis macrochirus)
LC50: =41.7g/L (96h, Cyprinus carpio)

Toxicity to
microorganisms-

Crustacea-

No informa�on available.

12.3. Bioaccumula�ve poten�al
Bioaccumula�onComponent Informa�on
Chemical name
Dimethyl sulfoxide
12.4. Mobility in soil
Mobility in soilPar��on coeﬃcient-1.35

No informa�on available.

12.5. Results of PBT and vPvB assessment
PBT and vPvB assessment
The product does not contain any substance(s) classiﬁed as PBT or vPvB.
Chemical name
Dimethyl sulfoxide
67-68-5

PBT and vPvB assessment
The substance is not PBT / vPvB

12.6. Endocrine disrup�ng proper�es
Endocrine disrup�ng proper�esThis product does not contain any known or suspected endocrine disruptors.

12.7. Other adverse eﬀects
Other adverse eﬀects

No informa�on available.

SECTION 13: Disposal considera�ons
13.1. Waste treatment methods
Waste from residues/unused productsContaminated packaging
Waste codes / waste designa�ons
according to EWC / AVV

Dispose of in accordance with local regula�ons. Dispose of waste in accordance withenvironmental legisla�on.
Do not reuse empty containers.
According to the European Waste Catalog, Waste Codes are not product speciﬁc, but
applica�on speciﬁc. Waste codes should be assigned by the user based on theapplica�on for which the product was used.

SECTION 14: Transport informa�on
IMDG
14.1
14.2
14.3
14.4

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group

Not regulated
Not regulated
Not regulated
Not regulated
Not applicable

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

21 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 14: Transport informa�on

RID

14.5
14.6

Environmental hazards
Special Precau�ons for Users
Special Provisions

Not applicable

14.7

Mari�me transport in bulk according
to IMO instruments

No informa�on available

None

Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable

14.1 UN number
14.2 UN proper shipping name14.3 Transport hazard class(es)14.4 Packing group
14.5 Environmental hazards
14.6 Special Precau�ons for Users
Special Provisions

ADR

14.1
14.2
14.3
14.4
14.5
14.6

IATA
14.1
14.2
14.3
14.4
14.5
14.6

None
Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions

None
Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions

Note:

None
None

SECTION 15: Regulatory informa�on
15.1. Safety, health and environmental regula�ons/legisla�on speciﬁc for the substance or mixtureNa�onal regula�ons
FranceOccupa�onal Illnesses (R-463-3, France)
Chemical nameFrench RG number
Dimethyl sulfoxide
RG 84
67-68-5
Germany
Water hazard class (WGK)

non-hazardous to water (nwg)

European Union
Take note of Direc�ve 98/24/EC on the protec�on of the health and safety of workers from the risks related to chemical agents at
work.

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

22 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 15: Regulatory informa�on
Authoriza�ons and/or restric�ons on use:
This product contains one or more substance(s) subject to restric�on (Regula�on (EC) No. 1907/2006 (REACH), Annex XVII)
Chemical nameRestricted substance per REACH
Substance subject to authoriza�on per
Annex XVIIREACH Annex XIV
Dimethyl sulfoxide - 67-68-5
75.
Persistent Organic Pollutants
Not applicable
Ozone-deple�ng substances (ODS) regula�on (EC) 1005/2009
Not applicable
Interna�onal Inventories
Contact supplier for inventory compliance status
15.2. Chemical safety assessment
Chemical Safety Report

No informa�on available

SECTION 16: Other informa�on
Key or legend to abbrevia�ons and acronyms used in the safety data sheet
Legend
ATE: Acute Toxicity Es�mate
SVHC: Substances of Very High Concern for Authoriza�on:
PBT: Persistent, Bioaccumula�ve, and Toxic (PBT) Substances
vPvB: Very Persistent and very Bioaccumula�ve (vPvB) Substances
Legend Sec�on 8: Exposure controls/personal protec�on
TWA
TWA (�me-weighted average)
Ceiling
Maximum limit value
SCBA
Self-contained breathing apparatus
Classiﬁca�on procedure
Classiﬁca�on according to Regula�on (EC) No. 1272/2008 [CLP]
Acute oral toxicity
Acute dermal toxicity
Acute inhala�on toxicity - gas
Acute inhala�on toxicity - vapor
Acute inhala�on toxicity - dust/mist
Skin corrosion/irrita�on
Serious eye damage/eye irrita�on
Respiratory sensi�za�on
Skin sensi�za�on
Mutagenicity
Carcinogenicity
Reproduc�ve toxicity
STOT - single exposure
STOT - repeated exposure
Acute aqua�c toxicity
Chronic aqua�c toxicity

SDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

STEL*

STEL (Short Term Exposure Limit)
Skin designa�on

Method Used
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
On basis of test data
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method

23 / 24

LymphoTrack® Dx Assays - MiSeqTM

SECTION 16: Other informa�on
Aspira�on hazard
Ozone

Calcula�on method
Calcula�on method

Key literature references and sources for data used to compile the SDS
Agency for Toxic Substances and Disease Registry (ATSDR)
U.S. Environmental Protec�on Agency ChemView Database
European Food Safety Authority (EFSA)
European Chemicals Agency (ECHA) Commitee for Risk Assessment (ECHA_RAC)
European Chemicals Agency (ECHA) (ECHA_API)
EPA (Environmental Protec�on Agency)
Acute Exposure Guideline Level(s) (AEGL(s))
U.S. Environmental Protec�on Agency Federal Insec�cide, Fungicide, and Roden�cide Act
U.S. Environmental Protec�on Agency High Produc�on Volume Chemicals
Food Research Journal
Hazardous Substance Database
Interna�onal Uniform Chemical Informa�on Database (IUCLID)
Japan GHS Classiﬁca�onAustralia Na�onal Industrial Chemicals No�ﬁca�on and Assessment Scheme (NICNAS)
NIOSH (Na�onal Ins�tute for Occupa�onal Safety and Health)Na�onal Library of Medicine's ChemID Plus (NLM CIP)
Na�onal Library of Medicine’s PubMed database (NLM PUBMED)
United States of America Na�onal Toxicology Program (NTP)New Zealand's Chemical Classiﬁca�on and Informa�on Database (CCID)
Organiza�on for Economic Co-opera�on and Development Environment, Health, and Safety Publica�ons
Organiza�on for Economic Co-opera�on and Development High Produc�on Volume Chemicals Program
Organiza�on for Economic Co-opera�on and Development Screening Informa�on Data Set
World Health Organiza�on
Issuing Date

27-Apr-2023

Revision Date

27-Apr-2023

Revision Note

Ini�al Release.

This safety data sheet complies with the requirements of Commission Regula�on (EU) 2020/878 of 18 June 2020 amending Regula�on(EC) No. 1907/2006
Disclaimer
The informa�on provided in this Safety Data Sheet is correct to the best of our knowledge, informa�on and belief at the date of its
publica�on. The informa�on given is designed only as a guidance for safe handling, use, processing, storage, transporta�on, disposal
and release and is not to be considered a warranty or quality speciﬁca�on. The informa�on relates only to the speciﬁc material
designated and may not be valid for such material used in combina�on with any other materials or in any process, unless speciﬁed in
the text.
End of Safety Data SheetSDS – LymphoTrack Dx Assays - MiSeq (CLP)-EN Rev. A | November 2023

24 / 24